Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
Símbolo de cotizaciónPLRZ
Nombre de la empresaPolyrizon Ltd
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoMr. Tomer Izraeli
Número de empleados1
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 29
DirecciónHaTidhar St. 5
CiudadRA'ANANA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísIsrael
Código postal- -
Teléfono97293740120
Sitio Webhttps://polyrizon-biotech.com/
Símbolo de cotizaciónPLRZ
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoMr. Tomer Izraeli
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos